OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Epidemiology Biomarkers & Prevention is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Medical Care Costs Associated with Cancer Survivorship in the United States	309
The Evolving Epidemiology of Nasopharyngeal Carcinoma	147
CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants	104
Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies	91
Sex Differences in Cancer Incidence and Survival: A Pan-Cancer Analysis	88
Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area	86
Biomarkers for the Early Detection of Hepatocellular Carcinoma	70
Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test	69
Radiomics Improves Cancer Screening and Early Detection	68
Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose–Response Meta-analysis	68
Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15–29 Years in the United States, 1999–2017: An Ecologic Study	62
Biomarkers and Strategies for Early Detection of Ovarian Cancer	55
Persistent Poverty and Cancer Mortality Rates: An Analysis of County-Level Poverty Designations	54
Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions	53
The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them	50
Cancer Progress and Priorities: Breast Cancer	49
The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies	48
Prevalence of Healthy Behaviors among Cancer Survivors in the United States: How Far Have We Come?	44
Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status	43
Pediatric Brain Tumors: Descriptive Epidemiology, Risk Factors, and Future Directions	43
Epidemiology and Outcomes of Young-Onset Esophageal Adenocarcinoma: An Analysis from a Population-Based Database	42
A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing—Predictors 5.1	40
Obstructive Sleep Apnea and Incident Cancer: A Large Retrospective Multicenter Clinical Cohort Study	39
Projected Reductions in Absolute Cancer–Related Deaths from Diagnosing Cancers Before Metastasis, 2006–2015	38
Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships	37

Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review	36
Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study	36
Updated Review of Major Cancer Risk Factors and Screening Test Use in the United States in 2018 and 2019, with a Focus on Smoking Cessation	35
Further Guidance in Implementing the Standardized 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score	35
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women	34
Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network	34
Head and Neck Cancer Survival Disparities by Race and Rural–Urban Context	33
Understanding Racial Disparities in Gastrointestinal Cancer Outcomes: Lack of Surgery Contributes to Lower Survival in African American Patients	32